Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

gut microbiota

  • You have access
    Impact of the Use of Proton Pump Inhibitors on Pembrolizumab Effectiveness for Advanced Urothelial Carcinoma
    IKKO TOMISAKI, MIRII HARADA, AKINORI MINATO, YUJIRO NAGATA, RIEKO KIMURO, KATSUYOSHI HIGASHIJIMA, KENICHI HARADA and NAOHIRO FUJIMOTO
    Anticancer Research March 2022, 42 (3) 1629-1634; DOI: https://doi.org/10.21873/anticanres.15638
  • You have access
    Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy
    KAZUYUKI HAMADA, KIYOSHI YOSHIMURA, YUYA HIRASAWA, MASAHIRO HOSONUMA, MASAKAZU MURAYAMA, YOICHIRO NARIKAWA, HIROTSUGU ARIIZUMI, RYOTARO OHKUMA, MIDORI SHIDA, YUTARO KUBOTA, SATOSHI MATSUKUMA, TOMOYUKI ISHIGURO, TAKEHIKO SAMBE, ATSUSHI HORIIKE, ATSUO KURAMASU, SATOSHI WADA, JUNJI TSURUTANI, EISUKE INOUE, NAOKI UCHIDA, YUJI KIUCHI, SHINICHI KOBAYASHI, ROBERT M. HOFFMAN and TAKUYA TSUNODA
    Anticancer Research October 2021, 41 (10) 4985-4993; DOI: https://doi.org/10.21873/anticanres.15312
  • You have access
    Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin
    VIRINDER SARHADI, LEO LAHTI, FARIDEH SABERI, OMAR YOUSSEF, ARTO KOKKOLA, TIINA KARLA, MILJA TIKKANEN, HILPI RAUTELIN, PAULI PUOLAKKAINEN, RASOUL SALEHI and SAKARI KNUUTILA
    Anticancer Research March 2020, 40 (3) 1325-1334; DOI: https://doi.org/10.21873/anticanres.14074
  • You have access
    The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in Healthy Adults: A Randomized, Double-blinded, Dose-response Study
    NIPITH CHAROENNGAM, ARASH SHIRVANI, TYLER A. KALAJIAN, ANJELI SONG and MICHAEL F. HOLICK
    Anticancer Research January 2020, 40 (1) 551-556; DOI: https://doi.org/10.21873/anticanres.13984
  • You have access
    The Impact of Antibiotics on Prognosis of Metastatic Renal Cell Carcinoma in Japanese Patients Treated With Immune Checkpoint Inhibitors
    KOSUKE UEDA, SATORU YONEKURA, NAOYUKI OGASAWARA, YOSHIHIRO MATSUNAGA, RYUJI HOSHINO, HIROFUMI KUROSE, KATSUAKI CHIKUI, KEIICHIRO UEMURA, MAKOTO NAKIRI, KIYOAKI NISHIHARA, MITSUNORI MATSUO, SHIGETAKA SUEKANE and TSUKASA IGAWA
    Anticancer Research November 2019, 39 (11) 6265-6271; DOI: https://doi.org/10.21873/anticanres.13836
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire